149 related articles for article (PubMed ID: 7547090)
1. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
Apseloff G; Wilner KD; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
[TBL] [Abstract][Full Text] [Related]
2. The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.
Blum RA; Schentag JJ; Gardner MJ; Wilner KD
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):35S-38S. PubMed ID: 7547092
[TBL] [Abstract][Full Text] [Related]
3. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
4. Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.
Wilner KD; Gardner MJ
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):39S-42S. PubMed ID: 7547093
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine does not alter the clearance or plasma binding of tenidap in healthy male volunteers.
Wilner KD; Gardner MJ
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):21S-24S. PubMed ID: 7547088
[TBL] [Abstract][Full Text] [Related]
6. Tenidap sodium decreases renal clearance and increases steady-state concentrations of lithium in healthy volunteers.
Apseloff G; Wilner KD; von Deutsch DA; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):25S-28S. PubMed ID: 7547089
[TBL] [Abstract][Full Text] [Related]
7. Effect of tenidap sodium on digoxin pharmacokinetics in healthy young men.
Dewland PM; Grimwood VC; Rapeport WG; Coates PE
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):43S-46S. PubMed ID: 7547094
[TBL] [Abstract][Full Text] [Related]
8. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.
Garg V; Blum R; Wilner KD; Jusko WJ
J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126
[TBL] [Abstract][Full Text] [Related]
9. Effect of sertraline on protein binding of warfarin.
Apseloff G; Wilner KD; Gerber N; Tremaine LM
Clin Pharmacokinet; 1997; 32 Suppl 1():37-42. PubMed ID: 9068934
[TBL] [Abstract][Full Text] [Related]
10. Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.
Gardner MJ; Wilner KD; Hansen RA; Fouda HG; McMahon GF
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):11S-15S. PubMed ID: 7547086
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
[TBL] [Abstract][Full Text] [Related]
12. The effect of tenidap on the anti-hypertensive efficacy of thiazide diuretics in patients treated for mild to moderate hypertension.
Rapeport WG; Grimwood VC; Korlipara K; Grillage MG; James I; Anderton JL; Selfridge DI
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):51S-55S. PubMed ID: 7547096
[TBL] [Abstract][Full Text] [Related]
13. The effect of tenidap on the anti-hypertensive efficacy of ACE inhibitors in patients treated for mild to moderate hypertension.
Rapeport WG; Grimwood VC; Hosie J; Sloan PM; Korlipara K; Silvert BD; James I; Mechie GL; Anderton JL
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):57S-61S. PubMed ID: 7547097
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole potentiates warfarin-induced prothrombin time prolongation.
Purkins L; Wood N; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):24-9. PubMed ID: 14616410
[TBL] [Abstract][Full Text] [Related]
15. Absence of interaction between tenoxicam and warfarin.
Eichler HG; Jung M; Kyrle PA; Rotter M; Korn A
Eur J Clin Pharmacol; 1992; 42(2):227-9. PubMed ID: 1618257
[TBL] [Abstract][Full Text] [Related]
16. Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Benedek IH; King SY; Powell RJ; Agra AM; Schary WL; Pieniaszek HJ
J Clin Pharmacol; 1992 Jun; 32(6):558-63. PubMed ID: 1634644
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
Karim A; Tolbert D; Piergies A; Hubbard RC; Harper K; Wallemark CB; Slater M; Geis GS
J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
[TBL] [Abstract][Full Text] [Related]
18. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
19. The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.
Caldwell JR; Kirby DS; Gardner MJ; Hansen RA
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):3S-9S. PubMed ID: 7547091
[TBL] [Abstract][Full Text] [Related]
20. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug.
Loose LD; Sipe JD; Kirby DS; Kraska AR; Weiner ES; Shanahan WR; Leeming MR; Farrow P; Stack CB; Ting N
Br J Rheumatol; 1993 Jun; 32 Suppl 3():19-25. PubMed ID: 7685226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
